If this article sounds similar to a recent experience that you or a loved one have suffered from, please don't hesitate to contact us online or call 859-578-4444 to schedule a free consultation!\r\n\r\nFosamax osteoporosis drug prescribed when women only has osteopenia\r\nAn excellent story on NPR suggests that millions of American women may have been taking a drug unnecessarily.\u00a0 The drug Fosamax is manufactured by Merck, a huge pharmaceutical company.\u00a0 The drug is approved by the FDA to treat osteoporosis, which is a\u00a0disease\u00a0of\u00a0bone\u00a0that leads to an increased risk of\u00a0fracture. In osteoporosis the\u00a0bone mineral density\u00a0(BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of proteins in bone is altered. Osteoporosis is defined by the\u00a0World Health Organization\u00a0(WHO) in women as a bone mineral density 2.5\u00a0standard deviations\u00a0below peak bone mass (20-year-old healthy female average) as measured by\u00a0DXA; the term "established osteoporosis" includes the presence of a\u00a0fragility fracture.\r\nThe problem is that Merck developed a Bone Density test that resulted in women having a much less serious condition called osteopenia appearing to require the drugs to treat osteoporosis.\u00a0 As a result millions of women with osteopenia were prescribed serious and expensive drugs that they did not need. osteopenia occurs more frequently in post-menopausal women as a result of the loss of estrogen. It can also be exacerbated by lifestyle factors such as lack of exercise, excess consumption of alcohol, smoking or prolonged use of glucocorticoid medications such as those prescribed for asthma.\u00a0 Women with osteopenia do not require medication.